Relationships between hepatic iron content and virologic response in chronic hepatitis C patients treated with interferon and ribavirin

American Journal of Gastroenterology

Volumn 100, Issue 2, 2005, Pages 332-337

  Rulyak, Stephen J ^b   Eng, Sue C ^b   Patel, Keyur ^b   McHutchison, John G ^b   Gordon, Stuart C ^b   Kowdley, Kris V ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; IRON; PEGINTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN; ANTIVIRUS AGENT; MACROGOL DERIVATIVE; VIRUS RNA;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HISTOLOGY; HUMAN; LIVER BIOPSY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS LOAD; BLOOD; CLASSIFICATION; CLINICAL TRIAL; DRUG COMBINATION; GENETICS; HEPATITIS C VIRUS; LIVER; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; IRON; LIVER; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RIBAVIRIN; RNA, VIRAL;

EID: 13944256260     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41112.x     Document Type: Article

References (27)

1. Van Thiel DH, Friedlander L, Faginoli S, et al. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-5.
2. Olynyk JK, Reddy KR, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
3. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to interferon therapy, and effect of iron depletion in chronic hepatitis C. Liver 1996;16:248-54.
4. Barton AL, Banner BF, Cable EE, et al. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 1995;103:419-24.
5. Ikura Y, Morimoto H, Johmura H, et al. Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C. Am J Gastroenterol 1996;91(7):1367-73.
6. Van Thiel DH, Friedlander L, Molloy PJ, et al. Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy. Hepatogastroenterology 1996;43(12):1557-61.
7. Fargion S, Fracanzani AL, Sampietro M, et al. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C. Eur J Gastroenterol Hepatol 1997;9(5):497-503.
8. Fontana RJ, Israel J, LeClair P, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial. Hepatology 2000;31(3):730-6.
9. Piperno A, Sampietro M, D'Alba R, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996;16(4):248-54.
10. Di Bisceglie AM, Bonkovsky HL, Chopra S, et al. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective, randomized, controlled trial. Hepatology 2000;32(1):135-8.
11. Pianko S, McHutchison JG, Gordon SC, et al. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection. J Interferon Cytokine Res 2002;22(4):483-9.
12. Distante S, Bjoro K, Hellum KB, et al. Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection. Liver 2002;22(3):269-75.
13. Boucher E, Bourienne A, Adams P, et al. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997;41(1):115-20.
14. Kakizaki S, Takagi H, Ichikawa T, et al. Histological change after interferon therapy in chronic hepatitis C in view of iron deposition in the liver. Biol Trace Elem Res 2000;73(2):151-62.
15. Di Bisceglie AM, Bacon BR, Kleiner DE, et al. Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. J Hepatol 1994;21(6):1109-12.
16. Fiel MI, Schiano TD, Guido M, et al. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin. Am J Clin Pathol 2000;113(1):35-9.
17. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998;339(21):1485-92.
18. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001;358(9286):958-65.
19. Emond MJ, Bronner MP, Carlson TH, et al. Quantitative study of the variability of hepatic iron concentrations. Clin Chem 1999;45:340-6.
20. Breslow NE, Day NE. Statistical methods in cancer research - The analysis of case-control studies. Lyon: International Agency for Research on Cancer, 1980.
21. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992;102(6):2108-13.
22. Ioannou GN, Kowdley KV. Iron, HFE mutations, and hepatocellular carcinoma: Is hepatic iron a carcinogen? Clin Gastroenterol Hepatol 2003;1(4):246-8.
23. Thorson JA, Smith KM, Gomez F, et al. Role of iron in T cell activation: TH1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IgG Mabs against the transferrin receptor and the iron chelator deferoxamine. Cell Immunol 1991;134(1):126-37.
24. Hultgren C, Milich DR, Weiland O, et al. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses. J Gen Virol 1998;79(Pt 10):2381-91.
25. Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fg12 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998;160(7):3487-93.
26. Taylor SL, Tung BY, Emond MJ, et al. Relationship between biochemical and histological iron score in patients with chronic hepatitis. Hepatology 2000;32:A405.
27. Walker EM, Walker SM. Effects of iron overload on the immune system. Ann Clin Lab Sci 2000;30(4):354-65.